<?xml version="1.0" encoding="UTF-8"?>
<p>Testing these assumptions could have important implications for epidemic management strategies. Accordingly, at least 10 clinical trials are currently underway to verify the efficacy of chloroquine and its derivates for COVID-19 (e.g., NCT04261517, 2/14/20; ChiCTR2000029826, 2/2/20) [
 <xref rid="B20-jcm-09-01138" ref-type="bibr">20</xref>]. Interestingly, hydroxychloroquine is a less toxic derivate of chloroquine that has demonstrated potential against Beta-CoVs [
 <xref rid="B21-jcm-09-01138" ref-type="bibr">21</xref>]. 
</p>
